UK markets closed

NVO Jan 2026 87.500 put

OPR - OPR Delayed price. Currency in USD
Add to watchlist
4.83000.0000 (0.00%)
As of 03:45PM EDT. Market open.
Full screen
Previous close4.8300
Open4.8300
Bid4.0000
Ask4.5000
Strike87.50
Expiry date2026-01-16
Day's range4.8300 - 4.8300
Contract rangeN/A
Volume10
Open interest11
  • Yahoo Finance

    Eli Lilly reports $2 billion from Mounjaro, Zepbound in Q1 2024

    Eli Lilly missed on total sales in the first quarter, but its GLP-1 drugs helped boost sales by 26% over those in Q1 2023.

  • Investor's Business Daily

    Breakouts In Focus: Google Goes Wild As Tasty IPO Sets Up

    As Google stock gaps up and gets volatile, Novo Nordisk sets up while a hot IPO and leading chipmaker break out.

  • GlobeNewswire

    Novo Nordisk A/S - share repurchase programme

    Bagsværd, Denmark, 1 May 2024 – On 6 February 2024, Novo Nordisk initiated a share repurchase programme in accordance with Article 5 of Regulation No 596/2014 of the European Parliament and Council of 16 April 2014 (MAR) and the Commission Delegated Regulation (EU) 2016/1052 of 8 March 2016 (the "Safe Harbour Rules"). This programme is part of the overall share repurchase programme of up to DKK 20 billion to be executed during a 12-month period beginning 6 February 2024. Under the programme init